Product Launch

Product Launch

Syntegrity

Pharma

CASE STUDY

The Challenge

A global pharmaceutical company had developed a new cancer vaccine that they were planning to launch. They wanted to maximize patient access to the vaccine, which would require getting public and private coverage for it. They knew that they had to bring together a variety of internal stakeholders, whose diverse perspectives and buy-in was necessary for a successful launch. One of the main challenges was that the vaccines business tended to operate in isolation from the rest of the company, and it needed to be better integrated into the company without losing its unique culture.

The Approach

32 people – directors, managers, and senior managers – gathered from across different parts of the organization, from marketing, health education, vaccines, finance, to policy. Their challenge was to determine how to ensure that everyone had optimal access to their novel vaccine.

Together, the team produced a 12-point agenda that covered topics such as disease awareness, integration, customer needs, prioritization & workload, etc. They mapped out scenarios for what would happen if they got the ideal coverage they wanted, if they didn’t, and so on. They produced strategic recommendations for coordinating campaigns across brands, for instituting better long-term planning to manage people’s workload, and for creating a core team responsible for integrating the vaccines business with the larger human health division.

The Results

The team was able to produce a thoughtful plan that pulled together representatives from multiple businesses, and execute upon it rapidly. They were able to secure public and private coverage for the vaccine at impressive speed. The vaccine is now widely known throughout North America.

Back

Central Question:

“What new and innovative ideas will enable us to help oncology patients, while maximizing the launch and ongoing success of our new therapy?”

Central Question:

“What new and innovative ideas will enable us to help oncology patients, while maximizing the launch and ongoing success of our new therapy?”

The Results:

$4 Billion Blockbuster

SOLVING AND CHANGE CAN BE INCREDIBLY FAST.

We welcome a conversation to share the formula for how Syntegrity has solved for solving.

Contact Us